YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 144 participants.
Also called NCT06048588
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 1/2
- Enrolled
- 144 participants
- Sponsor
- Beijing Inno Medicine Co., Ltd.
- Registry
-
NCT06048588
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06048588. Randomized; triple masking; primary purpose treatment. Start 2023-10-08 (actual); primary completion 2025-04-27 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
- Condition
- Atherosclerotic Cardiovascular Disease
- Intervention (Drug)
- YN001
- Intervention (Drug)
- Placebo for YN001
- Intervention (Drug)
- rosuvastatin calcium tablets
- Lead sponsor
- Beijing Inno Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct06048588- Content hash
ad7543c53dc4ac4fac60b00a1edaf51d453c27d92e137fd0a0b71e4358ce09ce